Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul;5(7):707-715.
doi: 10.1002/jac5.1622. Epub 2022 Apr 17.

Global resilience and new strategies needed for antimicrobial stewardship during the COVID-19 pandemic and beyond

Affiliations

Global resilience and new strategies needed for antimicrobial stewardship during the COVID-19 pandemic and beyond

Debra A Goff et al. J Am Coll Clin Pharm. 2022 Jul.

Abstract

Resilience is having the ability to respond to adversity proactively and resourcefully. The coronavirus disease 2019 (COVID-19) pandemic's profound impact on antimicrobial stewardship programs (ASP) requires clinicians to call on their own resilience to manage the demands of the pandemic and the disruption of ASP activities. This article provides examples of ASP resilience from pharmacists and physicians from seven countries with different resources and approaches to ASP-The United States, The United Kingdom, Canada, Nigeria, Lebanon, South Africa, and Colombia. The lessons learned pertain to providing ASP clinical services in the context of a global pandemic, developing new ASP paradigms in the face of COVID-19, leveraging technology to extend the reach of ASP, and conducting international collaborative ASP research remotely. This article serves as an example of how resilience and global collaboration is sustaining our ASPs by sharing new "how to" do antimicrobial stewardship practices during the COVID-19 pandemic.

Keywords: COVID‐19 pandemic; SARS‐CoV‐2; antimicrobial stewardship; pharmacists; physicians.

PubMed Disclaimer

Conflict of interest statement

Debra A. Goff; Timothy P. Gauthier; Bradley J. Langford; Pavel Prusakov; Ubaka Chukwuemka M; Benedict C. Nwomeh; Khalid A. Yunis; Therese Saad; Maria Virginia Villegas; Diane Ashiru‐Oredope and Pablo J. Sanchez: see conflict of interest disclosure form submitted with manuscript. Andrew Morris, Philip Howard, Dena van den Bergh, and Nela Martinez have no relevant conflicts of interest.

Figures

FIGURE 1
FIGURE 1
New paradigms in antimicrobial stewardship during COVID‐19. ASP antimicrobial stewardship programs

References

    1. Weiner‐Lastinger LM, Pattabiraman V, Konnor RY, et al. The impact of coronavirus disease 2019 (COVID‐19) on healthcare‐associated infections in 2020: a summary of data reported to the National Healthcare Safety Network. Infect Control Hosp Epidemiol. 2021;118:1–14. - PubMed
    1. Etienne C. Americas Report Surge in Drug‐Resistant Infections due to Misuse of Antimicrobials During Pandemic; 2021. https://www.paho.org/en/news/17-11-2021-americas-report-surge-drug-resis...
    1. Langford BJ, So M, Raybardhan S, et al. Antibiotic prescribing in patients with COVID‐19: rapid review and meta‐analysis. Clin Microbiol Infect. 2021;27(4):520–531. - PMC - PubMed
    1. Causey K, Fullman N, Sorensen RJD, et al. Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID‐19 pandemic in 2020: a modelling study. Lancet. 2021;398(10299):522–534. - PMC - PubMed
    1. Goff DA, Ashiru‐Oredope D, Cairns KA, et al. Global contributions of pharmacists during the COVID‐19 pandemic. J Am Coll Clin Pharm. 2020;3:1480–1492. - PMC - PubMed